Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

RNAC

Cartesian Therapeutics Inc

May 03 • 01:16PM ET

26.16

Dollar change +1.73
Percentage change 7.06	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWO IWC OMFS FESM VTWV

Index	RUT	P/E	-	EPS (ttm)	-49.77	Insider Own	27.99%	Shs Outstand	17.78M	Perf Week	24.37%
Market Cap	465.04M	Forward P/E	-	EPS next Y	-3.43	Insider Trans	32.59%	Shs Float	12.80M	Perf Month	72.95%
Income	-257.26M	PEG	-	EPS next Q	-0.89	Inst Own	11.42%	Short Float	4.99%	Perf Quarter	23.18%
Sales	26.00M	P/S	17.89	EPS this Y	92.22%	Inst Trans	-	Short Ratio	10.69	Perf Half Y	-24.84%
Book/sh	-81.55	P/B	-	EPS next Y	11.33%	ROA	-109.25%	Short Interest	0.64M	Perf Year	-24.19%
Cash/sh	4.33	P/C	6.05	EPS next 5Y	-	ROE	-49.79%	52W Range	11.66 - 42.60	Perf YTD	26.46%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.69%	ROI	-	52W High	-38.60%	Beta	0.51
Dividend TTM	-	Quick Ratio	1.33	Sales past 5Y	230.86%	Gross Margin	93.45%	52W Low	124.22%	ATR (14)	2.16
Dividend Ex-Date	-	Current Ratio	1.33	EPS Y/Y TTM	-700.10%	Oper. Margin	-332.32%	RSI (14)	74.17	Volatility	9.46% 11.99%
Employees	38	Debt/Eq	-	Sales Y/Y TTM	-76.53%	Profit Margin	-989.31%	Recom	1.00	Target Price	56.25
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-2667.79%	Payout	-	Rel Volume	2.29	Prev Close	24.43
Sales Surprise	187.55%	EPS Surprise	-1307.03%	Sales Q/Q	-50.78%	Earnings	Mar 07 BMO	Avg Volume	59.74K	Price	26.16
SMA20	38.29%	SMA50	35.61%	SMA200	-2.33%	Trades		Volume	82,136	Change	7.06%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Reiterated	H.C. Wainwright	Buy	$2 → $54
Apr-23-24	Initiated	Leerink Partners	Outperform	$39
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform	$1
Jun-14-22	Reiterated	Needham	Buy	$6 → $5
Jun-06-22	Initiated	SVB Leerink	Outperform	$7
Jun-15-21	Initiated	BTIG Research	Buy	$10
Jan-26-21	Upgrade	Mizuho	Neutral → Buy	$2.50 → $8
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Oct-01-20	Downgrade	Mizuho	Buy → Neutral	$2.50
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy	$8
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight	$10
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy	$33
Mar-30-17	Reiterated	UBS	Buy	$26

Show Previous Ratings

Apr-25-24 09:55AM	Wall Street Analysts Believe Cartesian Therapeutics, Inc. (RNAC) Could Rally 146.24%: Here's is How to Trade (Zacks)
Apr-22-24 04:30PM	Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting (Business Wire)
Apr-08-24 09:35AM	Down -30.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Cartesian Therapeutics, Inc. (RNAC) (Zacks)
Apr-04-24 07:30AM	Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
07:00AM	Cartesian Therapeutics Announces New Employment Inducement Grants (Business Wire)
05:41PM	Loading…
Apr-02-24 05:41PM	Insiders Are Buying These 11 Penny Stocks (Insider Monkey) -5.36%
Mar-28-24 04:05PM	Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split (GlobeNewswire)
Mar-14-24 09:35AM	Cartesian Therapeutics, Inc. (RNAC) Loses -24.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-07-24 11:51PM	RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.04%
07:00AM	Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 07:00AM	Cartesian Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 07:05AM	Cartesian Therapeutics Announces New Employment Inducement Grant (GlobeNewswire)
07:00AM	Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland (GlobeNewswire)
Feb-05-24 04:05PM	Cartesian Therapeutics Announces New Employment Inducement Grants (GlobeNewswire) -9.18%
Jan-22-24 09:19AM	Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? (InvestorPlace)
07:10AM	Loading…
Jan-08-24 07:10AM	Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity (GlobeNewswire) +5.87%
07:00AM	Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis (GlobeNewswire)
Nov-13-23 08:05AM	Selecta Biosciences Announces Merger with Cartesian Therapeutics (GlobeNewswire) -8.00%
Oct-31-23 04:03PM	Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi (GlobeNewswire)
Aug-24-23 06:21AM	The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab (American City Business Journals)
Aug-17-23 10:20PM	Q2 2023 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
08:15AM	Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics (GlobeNewswire)
Jul-14-23 07:08AM	Selecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26% (Simply Wall St.)
Jul-13-23 03:00PM	10 Best Revenue Growth Stocks to Buy (Insider Monkey)
Jun-03-23 08:20AM	Selecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five years (Simply Wall St.)
May-31-23 07:00AM	Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatology (GlobeNewswire)
May-09-23 06:06AM	Newsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.)
May-04-23 08:45AM	Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.96%
07:30AM	Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
04:05PM	Loading…
Apr-28-23 04:05PM	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire)
Apr-18-23 06:11AM	Investors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
Mar-27-23 07:07AM	Is Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? (Simply Wall St.) -5.67%
Mar-21-23 11:48AM	Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year (Benzinga)
03:30AM	Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint (GlobeNewswire)
Mar-06-23 05:59AM	Selecta Biosciences, Inc. (NASDAQ:SELB) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 01:24AM	Q4 2022 Selecta Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-02-23 09:25AM	Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-23 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Update (GlobeNewswire)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
08:00AM	Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-31-23 01:15PM	Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts (Benzinga)
Jan-17-23 11:33AM	Positive week for Selecta Biosciences, Inc. (NASDAQ:SELB) institutional investors who lost 34% over the past year (Simply Wall St.)
Jan-12-23 05:39AM	The Petri Dish: Moderna looks at new price tag for Covid vaccine (American City Business Journals) +5.44%
Jan-09-23 08:00AM	Selecta Biosciences Provides Business Update and Outlook for 2023 (GlobeNewswire) +8.13%
07:30AM	Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease (PR Newswire)
Dec-21-22 10:29AM	Shareholders in Selecta Biosciences (NASDAQ:SELB) have lost 89%, as stock drops 19% this past week (Simply Wall St.)
Dec-14-22 08:00AM	Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate Selection for IgA Nephropathy Program (GlobeNewswire)
Dec-01-22 05:43AM	The Petri Dish: bluebird gets $102M; BMS vet joins Selecta's C-suite (American City Business Journals)
Nov-28-22 08:00AM	Selecta Biosciences Announces Appointment of Blaine Davis as Chief Financial Officer (GlobeNewswire)
Nov-09-22 06:36AM	Selecta Biosciences Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) -8.39%
Nov-07-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim Healthcare Talks \| 4th Annual Immunology & Neurology Day (GlobeNewswire)
Nov-03-22 09:15AM	Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-27-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Oct-18-22 06:13AM	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? (Simply Wall St.)
Oct-11-22 08:00AM	Selecta Biosciences Announces Three Presentations at the Upcoming 29th Annual European Society of Gene and Cell Therapy (ESGCT) Conference (GlobeNewswire) +7.89%
Oct-10-22 06:10PM	Elevance Health's (ELV) Low-Cost MA Plans to Widen U.S. Base (Zacks) -7.88%
Sep-29-22 08:00AM	Selecta Biosciences Board Member, Timothy Springer, Ph.D., Wins Lasker Award for Seminal Discovery of Key Adhesion Molecules that Mediate Immune Cell Interactions (GlobeNewswire) -5.29%
Sep-12-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-06-22 08:00AM	Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-30-22 06:21AM	Selecta Biosciences (NASDAQ:SELB) Has A Pretty Healthy Balance Sheet (Simply Wall St.)
Aug-29-22 05:08PM	This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs (TheStreet.com)
Aug-12-22 09:30AM	10 Best One Dollar Stocks To Buy Now (Insider Monkey)
Aug-09-22 10:25AM	Need To Know: Analysts Are Much More Bullish On Selecta Biosciences, Inc. (NASDAQ:SELB) (Simply Wall St.)
Aug-06-22 08:25AM	What Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)? (Simply Wall St.)
Aug-04-22 09:05AM	Selecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates (Zacks) +13.94%
07:30AM	Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-22 08:00AM	Selecta Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-28-22 12:00PM	Selecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Jul-19-22 09:19AM	Top 10 Multibagger Penny Stocks to Buy in 2022 (Insider Monkey)
Jul-14-22 09:03AM	Strong week for Selecta Biosciences (NASDAQ:SELB) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.) -7.34%
Jul-12-22 07:49AM	Vertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program (Zacks) +8.07%
Jul-06-22 08:00AM	Selecta Biosciences to Participate at the Guggenheim I&I Spotlight Series Treg-based Therapies Conference (GlobeNewswire)
Jun-29-22 07:00AM	Surface Oncology Appoints Carsten Brunn to Board of Directors (GlobeNewswire)
Jun-20-22 07:43AM	BioMarin (BMRN) Stock Jumps 5.4%: Will It Continue to Soar? (Zacks)
Jun-14-22 08:59AM	Some Analysts Just Cut Their Selecta Biosciences, Inc. (NASDAQ:SELB) Estimates (Simply Wall St.) -6.25%
Jun-13-22 07:30AM	Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates (GlobeNewswire)
Jun-10-22 03:26PM	Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted (TheStreet.com) -7.32%
Jun-06-22 02:47PM	SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock (Benzinga) +13.13%
May-19-22 06:00PM	7 Cheap Biotech Stocks to Buy Now (InvestorPlace)
May-17-22 08:00AM	Selecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +9.23%
May-10-22 03:23PM	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? (Simply Wall St.)
May-05-22 08:45AM	Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-02-22 04:30PM	Selecta Biosciences Announces Six Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) (GlobeNewswire)
Apr-28-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
Apr-06-22 06:56PM	Selecta Biosciences Announces $38.7 Million Underwritten Offering (GlobeNewswire)
Apr-04-22 08:00AM	Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-10-22 09:25AM	Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-09-22 08:45AM	Amryt Pharma PLC Sponsored ADR (AMYT) Tops Q4 Earnings Estimates (Zacks) +10.76%
Mar-03-22 08:00AM	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update (GlobeNewswire)
Feb-09-22 08:00AM	Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference (GlobeNewswire)
Jan-11-22 11:48AM	Horizon (HZNP) Submits sBLA for Krystexxa Label Expansion (Zacks)
11:21AM	Selecta taps Ginkgo for deal worth up to $1.1B (American City Business Journals)
Jan-10-22 07:00AM	Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids (PR Newswire)
Jan-05-22 08:00AM	Selecta Biosciences to Participate at the 2022 H.C. Wainwright BioConnect Conference (GlobeNewswire)

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SPRINGER TIMOTHY A	Director	Mar 26 '24	Option Exercise	1.46	1,970,443	2,876,847	33,043,849	Mar 26 04:32 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.60	19,044	11,398	31,073,406	Mar 20 05:09 PM
SPRINGER TIMOTHY A	Director	Mar 18 '24	Buy	0.61	800	488	104,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.59	537,500	314,545	31,054,362	Mar 18 05:29 PM
SPRINGER TIMOTHY A	Director	Mar 15 '24	Buy	0.56	1,200	672	104,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.54	648,372	351,677	30,516,862	Mar 18 05:29 PM
SPRINGER TIMOTHY A	Director	Mar 14 '24	Buy	0.53	2,000	1,061	102,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 13 '24	Buy	0.58	3,200	1,868	100,818	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 12 '24	Buy	0.61	1,200	735	97,618	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 11 '24	Buy	0.65	1,200	785	96,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Mar 08 '24	Buy	0.66	4,800	3,187	95,218	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 07 '24	Buy	0.66	2,400	1,575	90,418	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Feb 06 '24	Buy	0.65	800	520	88,018	Mar 28 05:11 PM
SPRINGER TIMOTHY A	Director	Jan 17 '24	Buy	0.69	800	552	87,218	Mar 28 05:11 PM
Brunn Carsten	President and CEO	Sep 25 '23	Sale	1.06	2,932	3,108	783,081	Sep 26 06:01 PM
TRABER PETER G	Chief Medical Officer	Sep 25 '23	Sale	1.06	705	747	451,826	Sep 26 06:00 PM

Open in Screener

MORF

Morphic Holding Inc

May 03 • 01:16PM ET

29.61

Dollar change +0.90
Percentage change 3.13	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

MORF Morphic Holding Inc daily Stock Chart

Held by: VTI IWM VXF IBB IWO SCHA LABU VTWO VHT ITOT

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	22.64%	Shs Outstand	49.75M	Perf Week	5.49%
Market Cap	1.48B	Forward P/E	-	EPS next Y	-4.31	Insider Trans	-0.27%	Shs Float	38.75M	Perf Month	-1.66%
Income	-161.25M	PEG	-	EPS next Q	-0.97	Inst Own	84.22%	Short Float	16.14%	Perf Quarter	-14.79%
Sales	0.00M	P/S	-	EPS this Y	-9.58%	Inst Trans	-1.45%	Short Ratio	13.77	Perf Half Y	47.68%
Book/sh	13.25	P/B	2.24	EPS next Y	-9.68%	ROA	-28.67%	Short Interest	6.25M	Perf Year	-42.16%
Cash/sh	13.15	P/C	2.25	EPS next 5Y	-	ROE	-29.59%	52W Range	19.34 - 63.08	Perf YTD	2.53%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-35.64%	ROI	-24.25%	52W High	-53.06%	Beta	1.47
Dividend TTM	-	Quick Ratio	38.17	Sales past 5Y	134.56%	Gross Margin	-109.40%	52W Low	53.06%	ATR (14)	1.42
Dividend Ex-Date	-	Current Ratio	38.17	EPS Y/Y TTM	-109.60%	Oper. Margin	0.00%	RSI (14)	49.74	Volatility	4.49% 4.54%
Employees	121	Debt/Eq	0.00	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.40	Target Price	56.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-0.54%	Payout	-	Rel Volume	0.45	Prev Close	28.71
Sales Surprise	-	EPS Surprise	3.70%	Sales Q/Q	-100.00%	Earnings	Apr 25 BMO	Avg Volume	453.94K	Price	29.61
SMA20	3.24%	SMA50	-8.88%	SMA200	-14.33%	Trades		Volume	122,523	Change	3.13%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-23	Initiated	Citigroup	Buy	$46
Sep-25-23	Reiterated	Stifel	Hold	$61 → $33
Sep-25-23	Downgrade	BTIG Research	Buy → Neutral
Aug-09-23	Downgrade	Stifel	Buy → Hold	$69 → $61
Sep-07-22	Initiated	Stifel	Buy	$44
Jul-20-22	Initiated	SVB Leerink	Outperform	$45
Mar-31-22	Initiated	Canaccord Genuity	Buy	$68
Feb-11-22	Initiated	BTIG Research	Buy	$64
Dec-08-21	Initiated	Wells Fargo	Overweight	$81
Oct-26-20	Initiated	RBC Capital Mkts	Outperform	$35
Jul-22-19	Initiated	Wells Fargo	Outperform
Jul-22-19	Initiated	Jefferies	Buy
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BMO Capital Markets	Outperform	$30

Show Previous Ratings

Apr-25-24 01:53PM	MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024 (InvestorPlace)
08:37AM	Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review (GuruFocus.com)
07:00AM	Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 (GlobeNewswire)
Apr-24-24 12:00PM	What Makes Morphic (MORF) a New Buy Stock (Zacks)
Mar-20-24 01:57PM	MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF) (GlobeNewswire)
08:00AM	Loading…
Mar-19-24 08:00AM	Morphic Appoints Dr. Simon Cooper as Chief Medical Officer (GlobeNewswire)
Mar-05-24 04:05PM	Morphic to Participate in March Investor Conferences (GlobeNewswire)
Feb-26-24 09:55AM	Wall Street Analysts See a 56.18% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High? (Zacks)
Feb-22-24 07:00AM	Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 (GlobeNewswire)
Feb-08-24 09:55AM	Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 57.22%: Read This Before Placing a Bet (Zacks) +5.13%
Jan-18-24 01:04AM	Morphic Holding Inc CEO Praveen Tipirneni Sells 13,923 Shares (GuruFocus.com)
Jan-05-24 09:55AM	Wall Street Analysts Believe Morphic Holding, Inc. (MORF) Could Rally 110.28%: Here's is How to Trade (Zacks)
Jan-03-24 04:05PM	Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.57%
Dec-20-23 09:55AM	Does Morphic Holding, Inc. (MORF) Have the Potential to Rally 92.88% as Wall Street Analysts Expect? (Zacks) -5.01%
Dec-01-23 03:59PM	Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors (Business Wire)
09:55AM	Loading…
09:55AM	Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High? (Zacks)
Nov-15-23 09:55AM	Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet (Zacks)
Nov-10-23 08:00AM	Morphic to Present at November Investor Conferences (GlobeNewswire)
Nov-09-23 12:00PM	Morphic Holding, Inc. (MORF) Moves to Buy: Rationale Behind the Upgrade (Zacks) -6.27%
Nov-06-23 04:24PM	Morphic Corporation: Company Investigated by the Portnoy Law Firm (GlobeNewswire) -6.20%
Nov-03-23 08:46AM	Morphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ... (GuruFocus.com) +8.20%
07:00AM	Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 (GlobeNewswire)
Oct-09-23 08:00AM	Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set (GlobeNewswire)
Sep-28-23 06:27AM	The Petri Dish: Ginkgo, Pfizer sign $331M deal; Leqembi OK'd in Japan (American City Business Journals)
Sep-26-23 04:10PM	Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence (GlobeNewswire) -7.82%
Sep-25-23 04:08PM	The Surprise That Prompted Morphic Therapeutic To Dump 55% Over Two Days (Investor's Business Daily) -36.91%
12:58PM	Morphic Therapeutic stock nosedives on disappointing trial data (American City Business Journals)
Sep-22-23 05:30PM	Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023 (GlobeNewswire) -28.64%
Sep-09-23 01:01PM	Morphic Holding Inc CFO and COO Marc Schegerin Sells 20,000 Shares (GuruFocus.com)
Aug-29-23 08:00AM	Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference (GlobeNewswire)
04:05PM	Loading…
Aug-09-23 04:05PM	Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) -6.63%
Aug-07-23 06:24AM	Morphic Holding, Inc.'s (NASDAQ:MORF) large institutional owners must be happy as stock continues to impress, up 4.4% over the past week (Simply Wall St.)
Aug-03-23 08:55AM	Morphic Holding, Inc. (MORF) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:05AM	Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023 (GlobeNewswire)
Jun-08-23 03:22PM	3 Stocks That Could Skyrocket by This Time Next Summer (InvestorPlace)
Jun-06-23 04:05PM	Morphic to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-26-23 03:31PM	Here's Why We're Not At All Concerned With Morphic Holding's (NASDAQ:MORF) Cash Burn Situation (Simply Wall St.)
May-22-23 05:23PM	Inside Scoop: 10 Mid-Cap Stocks with Recent Insider Purchases (Insider Monkey)
May-12-23 08:30AM	Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-11-23 08:00AM	Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis (GlobeNewswire)
May-07-23 07:40PM	Insiders Pour Millions Into These 2 Strong Buy Stocks Heres Why You Might Want to Steer Toward Them Too (TipRanks)
May-06-23 08:13AM	Morphic Holding Founder Acquires 16% More Stock \ (Simply Wall St.)
May-05-23 10:30AM	Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
09:23AM	Q1 2023 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 12:13AM	Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering (GlobeNewswire) +5.57%
May-02-23 04:02PM	Morphic Therapeutic Announces Proposed Public Offering (GlobeNewswire)
Apr-30-23 08:10AM	What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
Apr-29-23 08:25AM	3 Biotech Buyout Targets to Watch (Motley Fool)
Apr-27-23 06:10AM	The Zacks Analyst Blog Highlights Biogen, Incyte, Morphic Therapeutic and bluebird bio (Zacks)
Apr-26-23 07:06AM	Biotech Stock Roundup: BIIB's Q1 Results, ARWR Up on Data, INCY & BLUE Offer Updates (Zacks)
Apr-25-23 11:54AM	Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars (Benzinga) +7.28%
08:15AM	Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures (GlobeNewswire)
06:59AM	Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023 (GlobeNewswire)
Apr-24-23 04:01PM	Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023 (GlobeNewswire)
Apr-18-23 10:56AM	Morphic Holding (NASDAQ:MORF) delivers shareholders strong 41% CAGR over 3 years, surging 20% in the last week alone (Simply Wall St.)
04:20AM	Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last? (Zacks)
Apr-09-23 01:19PM	7 Biotech Stocks to Buy for 100% Returns (InvestorPlace)
Mar-18-23 08:29AM	Some Analysts Just Cut Their Morphic Holding, Inc. (NASDAQ:MORF) Estimates (Simply Wall St.)
Mar-03-23 09:05AM	Morphic to Present at TD Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-24-23 05:26AM	Morphic Holding Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Feb-23-23 08:00AM	Morphic Announces Corporate Highlights and Financial Results for the Full Year 2022 (GlobeNewswire)
Feb-15-23 09:04AM	Revenue Downgrade: Here's What Analysts Forecast For Morphic Holding, Inc. (NASDAQ:MORF) (Simply Wall St.)
Feb-14-23 08:00AM	Morphic to Present at SVB Leerink Global Healthcare Conference (GlobeNewswire) +5.49%
Jan-26-23 05:54AM	The Petri Dish: Morphic, J&J part ways; FDA committee to review another Biogen drug (American City Business Journals)
Jan-13-23 07:26AM	Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Jan-05-23 09:09AM	Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-22 06:48AM	Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation (Simply Wall St.)
Nov-22-22 08:00AM	Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis (GlobeNewswire)
Nov-09-22 08:00AM	Morphic Announces Participation in 2022 Jefferies London Healthcare Conference (GlobeNewswire)
Nov-04-22 06:29AM	Industry Analysts Just Made An Upgrade To Their Morphic Holding, Inc. (NASDAQ:MORF) Revenue Forecasts (Simply Wall St.)
Nov-02-22 09:15AM	Morphic Holding, Inc. (MORF) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022 (GlobeNewswire)
Oct-28-22 12:07PM	Vertex (VRTX) Beats on Q3 Earnings, Ups 2022 Sales Guidance (Zacks) +7.22%
Oct-27-22 12:26PM	BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View (Zacks)
Oct-25-22 04:05PM	Morphic Presents New Positive MORF-057 Phase 1 Data at American College of Gastroenterology Annual Meeting 2022 (GlobeNewswire) +9.13%
01:59PM	Biogen (BIIB) Beats on Q3 Earnings & Sales, Raises 2022 Outlook (Zacks)
Oct-24-22 08:00AM	Morphic Announces Complete Enrollment of EMERALD-1 Main Cohort Ahead of Projections (GlobeNewswire)
Oct-20-22 01:19PM	Moderna (MRNA) Gets CHMP Nod for Omicron BA.4, BA.5 Booster Jab (Zacks)
Oct-10-22 08:00AM	Morphic Presents New Positive MORF-057 Phase 1 Data at UEG Week 2022 (GlobeNewswire)
Sep-30-22 01:20PM	Sarepta (SRPT) Seeks FDA Nod for DMD Gene Therapy Candidate (Zacks)
10:22AM	Those who invested in Morphic Holding (NASDAQ:MORF) three years ago are up 66% (Simply Wall St.)
Sep-29-22 12:00PM	EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster (Zacks)
10:15AM	Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last? (Zacks)
Sep-28-22 12:00PM	Morphic Congratulates Timothy A. Springer, PhD as 2022 Albert Lasker Basic Medical Research Award Honoree (GlobeNewswire) +7.31%
Sep-27-22 12:46PM	Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids (Zacks) +6.22%
Sep-26-22 12:39PM	Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why (Zacks)
11:17AM	AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication (Zacks)
Sep-23-22 11:14AM	Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris (Zacks)
11:02AM	Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK (Zacks)
Sep-22-22 01:28PM	Eli Lilly (LLY) Gets FDA Nod for RET Inhibitor in Solid Tumors (Zacks)
Sep-21-22 11:44AM	AstraZeneca (AZN) Gets EU Nod for Evusheld to Treat COVID (Zacks)
07:00AM	Morphic Celebrates Foundational Integrin Research Published in Cell (GlobeNewswire)
Sep-20-22 12:10PM	AbbVie (ABBV) Gets CHMP Nod for Skyrizi in a Third Indication (Zacks)
Sep-19-22 12:28PM	Sanofi (SNY) Gets CHMP Nod for Enjaymo in Hemolytic Anemia (Zacks)
12:21PM	Merck's (MRK) Pneumococcal Jab Gets CHMP Endorsement for Kids (Zacks)
Sep-16-22 11:42AM	Eloxx (ELOX) Down After Cystic Fibrosis Study Fails to Meet Goal (Zacks)
Sep-15-22 12:15PM	J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up (Zacks)
11:54AM	Pfizer (PFE) Starts Late-Stage Study on Influenza Vaccine (Zacks)
Sep-14-22 01:33PM	Key Factors Driving Merck's (MRK) Outperformance This Year (Zacks)

Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rogers Bruce	PRESIDENT	Mar 27 '24	Option Exercise	4.32	7,400	31,932	149,883	Mar 28 07:00 PM
Tipirneni Praveen P.	CEO	Jan 16 '24	Sale	27.49	13,923	382,753	42,013	Jan 17 07:04 PM
Rogers Bruce	President	Jan 16 '24	Sale	27.49	6,314	173,576	142,036	Jan 17 07:02 PM
SCHEGERIN MARC	CFO and COO	Jan 16 '24	Sale	27.49	6,041	166,071	37,460	Jan 17 07:03 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 16 '24	Sale	27.49	5,089	139,900	34,992	Jan 17 07:01 PM
DeVaul William	General Counsel and Secretary	Jan 16 '24	Sale	27.49	4,509	123,956	23,029	Jan 17 07:00 PM
DeVaul William	General Counsel and Secretary	Jan 14 '24	Option Exercise	0.00	3,250	0	27,538	Jan 17 07:00 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 14 '24	Option Exercise	0.00	3,470	0	40,081	Jan 17 07:01 PM
Rogers Bruce	President	Jan 14 '24	Option Exercise	0.00	5,070	0	148,350	Jan 17 07:02 PM
Tipirneni Praveen P.	CEO	Jan 14 '24	Option Exercise	0.00	12,500	0	55,936	Jan 17 07:04 PM
SCHEGERIN MARC	CFO and COO	Jan 14 '24	Option Exercise	0.00	4,690	0	43,501	Jan 17 07:03 PM
SCHEGERIN MARC	CFO and COO	Jan 13 '24	Option Exercise	0.00	14,675	0	38,811	Jan 17 07:03 PM
Tipirneni Praveen P.	CEO	Jan 13 '24	Option Exercise	0.00	29,500	0	43,436	Jan 17 07:04 PM
Rogers Bruce	President	Jan 13 '24	Option Exercise	0.00	15,225	0	143,280	Jan 17 07:02 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 13 '24	Option Exercise	0.00	12,675	0	36,611	Jan 17 07:01 PM
DeVaul William	General Counsel and Secretary	Jan 13 '24	Option Exercise	0.00	10,950	0	24,288	Jan 17 07:00 PM
SLATTERY JOSEPH P	Director	Nov 13 '23	Buy	20.60	2,400	49,436	9,066	Nov 14 07:04 PM
Edwards Martin	Director	Nov 13 '23	Buy	20.54	2,376	48,803	2,376	Nov 15 07:00 PM
SCHEGERIN MARC	CFO and COO	Sep 07 '23	Option Exercise	15.00	20,000	300,000	44,136	Sep 08 07:00 PM
SCHEGERIN MARC	CFO and COO	Sep 07 '23	Sale	54.34	20,000	1,086,849	24,136	Sep 08 07:00 PM
Tipirneni Praveen P.	President and CEO	Aug 01 '23	Option Exercise	4.32	3,597	15,539	17,533	Aug 03 06:58 PM
Tipirneni Praveen P.	President and CEO	Aug 01 '23	Sale	57.04	3,597	205,187	13,936	Aug 03 06:58 PM
Tipirneni Praveen P.	President and CEO	Jul 03 '23	Option Exercise	4.32	3,597	15,539	17,533	Jul 06 07:02 PM
Tipirneni Praveen P.	President and CEO	Jul 03 '23	Sale	57.04	3,597	205,178	13,936	Jul 06 07:02 PM
Tipirneni Praveen P.	President and CEO	Jun 12 '23	Option Exercise	4.32	840	3,629	14,776	Jun 14 07:04 PM
Tipirneni Praveen P.	President and CEO	Jun 12 '23	Sale	63.01	840	52,929	13,936	Jun 14 07:04 PM
DeVaul William	General Counsel and Secretary	Jun 07 '23	Sale	60.05	7,756	465,742	13,338	Jun 09 07:00 PM
Tipirneni Praveen P.	President and CEO	Jun 01 '23	Option Exercise	4.32	3,597	15,539	17,533	Jun 02 07:01 PM
Tipirneni Praveen P.	President and CEO	Jun 01 '23	Sale	57.14	3,597	205,519	13,936	Jun 02 07:01 PM
DeVaul William	General Counsel and Secretary	May 24 '23	Sale	60.00	100	6,000	21,094	May 25 08:44 PM
Farrell Robert E Jr	SVP Finance and CAO	May 23 '23	Option Exercise	4.32	10,000	43,200	33,708	May 25 08:45 PM
Farrell Robert E Jr	SVP Finance and CAO	May 23 '23	Sale	60.00	10,000	600,000	23,708	May 25 08:45 PM
DeVaul William	General Counsel and Secretary	May 23 '23	Sale	60.03	3,802	228,236	21,194	May 25 08:44 PM
Farrell Robert E Jr	SVP Finance and CAO	May 08 '23	Option Exercise	4.32	11,486	49,620	23,708	May 10 07:02 PM
Rogers Bruce	President	May 05 '23	Option Exercise	4.32	16,000	69,042	133,055	May 09 07:03 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

RNAC

Cartesian Therapeutics Inc

MORF

Morphic Holding Inc

Upgrade your FINVIZ experience